Alana Hippensteele

The trial demonstrated that the combination of lenvatinib, pembrolizumab, and transarterial chemoembolization (TACE) significantly improves progression-free survival and objective response rates compared to TACE alone.

In 19th century Europe, puerperal fever, also known as childbed fever, was a significant clinical health problem that resulted in high rates of maternal mortality.

The FDA faces a multitude of challenges in regulating artificial intelligence (AI) and machine learning (ML) medical devices.

Pharmacogenomic testing can help identify patients' genetic profiles, revealing why certain drugs may be less effective or cause adverse effects.

The KEYNOTE-756 and CheckMate 7FL trials show this combination improves pathological complete response rates in this patient population.

The guidelines emphasize the importance of vaccination, risk assessment, and preparedness for immunocompromised patients who are traveling post-transplant.

These therapies are being investigated in earlier lines, with several new treatments in development.

Key Takeaways The gut microbiome significantly influences cancer prognosis and immunotherapy response, with specific bacteria linked to treatment outcomes.

ASCO is prioritizing the expansion of pharmacist involvement in its organization by recognizing pharmacists' contributions to safety standards, quality improvement initiatives, and certification programs.

Two clinical trials with MRD monitoring may be practice changing: TRACERx and AEGEAN.